An Atypical Case of Fulminant Interstitial Pneumonitis Induced by Carbamazepine

Title: An Atypical Case of Fulminant Interstitial Pneumonitis Induced by Carbamazepine

Volume: 4 Issue: 1

Author(s): Hideyuki Narita, Takuro Ozawa, Takahisa Nishiyama, Shohei Matsumoto, Seigo Watanabe and Atsushi Isshiki

Affiliation:

Keywords: Carbamazepine, drug-induced interstitial pneumonitis

Abstract: Carbamazepine is a therapeutic anticonvulsant, used to manage pain. We often use it to treat trigeminal and post-herpes zoster neuralgias. Interstitial pneumonitis (IP) is a known adverse consequence of using carbamazepine, with bronchiolitis obliterans and organizing pneumonitis. (BOOP) drug-induced IP as typical examples. Here we described a patient with post-herpes zoster neuralgia, who suffered from drug-induced acute IP that differed from cases typically induced by carbamazepine.

Cite this article as:

Narita Hideyuki, Ozawa Takuro, Nishiyama Takahisa, Matsumoto Shohei, Watanabe Seigo and Isshiki Atsushi, An Atypical Case of Fulminant Interstitial Pneumonitis Induced by Carbamazepine, Current Drug Safety 2009; 4 (1) . https://dx.doi.org/10.2174/157488609787354486